Integrated offer

 

 

PX'Therapeutics differs from conventional CMOs by its integrated offer, which starts at the earliest stages of research (sequence optimisation, expression tests, feasibility studies : various expression systems can be tested - E.coli, yeasts, mammalian cells) and continues through to the manufacturing of batches for proof-of-concept studies (toxicology, clinical phase I and phase II). Our vision is to help our customers add value to their projects by offering dedicated solutions: a multi-disciplinary, flexible and committed team, and small-scale production capacities, which are particularly adapted to the needs and constraints of biotech companies.